ATE414281T1 - Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k - Google Patents

Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k

Info

Publication number
ATE414281T1
ATE414281T1 AT06016205T AT06016205T ATE414281T1 AT E414281 T1 ATE414281 T1 AT E414281T1 AT 06016205 T AT06016205 T AT 06016205T AT 06016205 T AT06016205 T AT 06016205T AT E414281 T1 ATE414281 T1 AT E414281T1
Authority
AT
Austria
Prior art keywords
pi3k
phenylthiazole ligand
immobilized
phenylthiazole
ligand
Prior art date
Application number
AT06016205T
Other languages
English (en)
Inventor
Moore Giovanna Bergamini
Andrew Cansfield
Nigel Ramsden
Gitte Neubauer
Original Assignee
Cellzome Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellzome Ag filed Critical Cellzome Ag
Application granted granted Critical
Publication of ATE414281T1 publication Critical patent/ATE414281T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
AT06016205T 2006-08-03 2006-08-03 Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k ATE414281T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06016205A EP1887359B1 (de) 2006-08-03 2006-08-03 Verfahren zur Identifizierung von Molekülen die mit PI3K interagieren und Verfahren zur Reinigung von PI3K

Publications (1)

Publication Number Publication Date
ATE414281T1 true ATE414281T1 (de) 2008-11-15

Family

ID=37635850

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06016205T ATE414281T1 (de) 2006-08-03 2006-08-03 Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k

Country Status (11)

Country Link
US (1) US8153389B2 (de)
EP (1) EP1887359B1 (de)
JP (1) JP5234668B2 (de)
CN (1) CN101563612B (de)
AT (1) ATE414281T1 (de)
AU (1) AU2007280631B2 (de)
CA (1) CA2658904A1 (de)
DE (1) DE602006003651D1 (de)
DK (1) DK1887359T3 (de)
ES (1) ES2317382T3 (de)
WO (1) WO2008015013A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0716239A2 (pt) 2006-08-30 2013-08-13 Cellzome Ltd derivados de triazol como inibidores de cinase
AU2008328882A1 (en) 2007-11-27 2009-06-04 Cellzome Limited Amino triazoles as PI3K inhibitors
DK2245181T3 (da) * 2008-02-04 2012-02-06 Cellzome Ag Selektivitetsprofilering af PI3K-interagerende molekyler med multiple mål
EP2286232B1 (de) * 2008-05-16 2012-02-29 Cellzome Ag Verfahren zur identifizierung von mit parp wechselwirkenden molekülen und zur aufreinigung von parp-proteinen
WO2010092015A1 (en) 2009-02-10 2010-08-19 Cellzome Limited Urea triazololo [1, 5-a] pyridine derivatives as pi3k inhibitors
ES2529205T3 (es) 2009-03-13 2015-02-17 Cellzome Limited Derivados de pirimidina como inhibidores de mTOR
CA2757671A1 (en) 2009-04-03 2010-10-07 Cellzome Ag Methods for the identification of kinase interacting molecules and for the purification of kinase proteins
EP2432782A1 (de) 2009-05-20 2012-03-28 Cellzome Ag Verfahren zur identifizierung von mit phosphatidylinositkinase wechselwirkenden molekülen und zur aufreinigung von phosphatidylinositkinaseproteinen
EP2542536B1 (de) 2010-03-04 2015-01-21 Cellzome Limited Morpholinsubstituierte Harnstoff-Derivate als mTOR-Hemmer
WO2012136622A1 (en) 2011-04-04 2012-10-11 Cellzome Limited Dihydropyrrolo pyrimidine derivatives as mtor inhibitors
WO2013041652A1 (en) 2011-09-21 2013-03-28 Cellzome Limited Morpholino substituted urea or carbamate derivatives as mtor inhibitors
KR20140084130A (ko) 2011-10-07 2014-07-04 셀좀 리미티드 Mtor 억제제로서의 모르폴리노 치환된 바이사이클릭 피리미딘 우레아 또는 카르바메이트 유도체
WO2014144858A1 (en) * 2013-03-15 2014-09-18 Icahn School Of Medicine At Mount Sinai Therapeutic methods for treating solid tumors and related diagnostic methods
CN115754306A (zh) * 2022-12-02 2023-03-07 中国科学院生态环境研究中心 化合物下拉靶点蛋白的方法
CN116773823A (zh) * 2023-06-25 2023-09-19 济宁医学院附属医院 一种快速鉴定与蛋白相互作用的小分子代谢物配体的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952512A (en) * 1984-06-22 1990-08-28 Loskutoff David J Gene encoding an inhibitor of tissue-type and urokinase-type plasminogen activators
US5994082A (en) * 1994-08-26 1999-11-30 Mach; Bernard Methods for the identification of inhibitors which suppress the activity of proteins displaying CIITA activity
WO1998020126A1 (en) * 1996-11-01 1998-05-14 Onyx Pharmaceuticals, Inc. Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof
AR038703A1 (es) * 2002-02-28 2005-01-26 Novartis Ag Derivados de 5-feniltiazol y uso como inhibidor de quinasa p i 3
MXPA06002997A (es) * 2003-09-18 2007-02-08 Conforma Therapeutics Corp Novedosos compuestos heterociclicos como inhibidores- hsp90.
SE0402735D0 (sv) * 2004-11-09 2004-11-09 Astrazeneca Ab Novel compounds
PL1891446T3 (pl) 2005-06-14 2013-08-30 Cellzome Gmbh Sposób identyfikacji nowych związków oddziałujących z enzymami
DK2245181T3 (da) 2008-02-04 2012-02-06 Cellzome Ag Selektivitetsprofilering af PI3K-interagerende molekyler med multiple mål

Also Published As

Publication number Publication date
US20100055711A1 (en) 2010-03-04
ES2317382T3 (es) 2009-04-16
US8153389B2 (en) 2012-04-10
WO2008015013A1 (en) 2008-02-07
EP1887359B1 (de) 2008-11-12
DK1887359T3 (da) 2009-03-02
JP5234668B2 (ja) 2013-07-10
AU2007280631A1 (en) 2008-02-07
EP1887359A1 (de) 2008-02-13
JP2010500870A (ja) 2010-01-14
DE602006003651D1 (de) 2008-12-24
CA2658904A1 (en) 2008-02-07
CN101563612B (zh) 2013-05-29
AU2007280631B2 (en) 2013-02-21
HK1111218A1 (en) 2008-08-01
CN101563612A (zh) 2009-10-21

Similar Documents

Publication Publication Date Title
ATE417274T1 (de) Verfahren zur identifizierung von mit zap-70 wechselwirkenden molekülen und zur zap-70- reinigung
ATE414281T1 (de) Verfahren zur identifizierung von molekülen die mit pi3k interagieren und verfahren zur reinigung von pi3k
Coninx et al. Hippocampal and cortical tissue-specific epigenetic clocks indicate an increased epigenetic age in a mouse model for Alzheimer’s disease
ATE489482T1 (de) Verfahren zur herstellung von hybridsubstraten mit dna und antikörpern sowie verwendungen davon
NZ609824A (en) Immunochromatography devices, methods and kits
WO2010027446A3 (en) Synaptic vesicle cycling assays and systems
WO2006124644A3 (en) Protein and antibody profiling using small molecule microarrays
WO2008082713A3 (en) Integrated semiconductor bioarray
WO2004046687A3 (en) Methods of biosensing using fluorescent polymers and quencher-tether-ligand bioconjugates
WO2008076365A3 (en) Analyte sensors, methods for preparing and using such sensors, and methods of detecting analyte activity
WO2008027162A3 (en) 129xe biosensors and their use
WO2005111233A3 (en) Methods and kits to detect hereditary angioedema type iii
WO2007056680A3 (en) Methods and arrays for identifying human microflora
ATE545030T1 (de) Testverfahren für nukleinsäurebindendes protein auf biochipbasis
EP1243659A4 (de) Verfahren zur erkennung von zielnukleinsauren
WO2007050979A3 (en) Real time nucleic acid detection in vivo using protein complementation
WO2006031644A3 (en) Immobilized probes and methods of detecting conformationally altered prion proteins
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
EP2507619A4 (de) Verfahren und system zur bindungsverhaltensanalyse
Pathan et al. Enzymes as indispensable markers in disease diagnosis
ATE343789T1 (de) Biomolekulares kinetik-messverfahren mit hilfe von einem durchfluss-mikroarray
WO2005059163A3 (en) Methods, compositions, and kits for analysis of enzyme activity in cells
WO2007002463A3 (en) Methods for genotype screening using magnetic particles
DE602005018316D1 (de) Verfahren zum Nachweis einer Zielsubstanz unter Verwendung einer Nukleinsäuresonde
SG148027A1 (en) Methods for identifying combinations of entities as therapeutics

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1887359

Country of ref document: EP